Episode 17 – GLP-1 in Type 1 Diabetes: beyond weight loss, towards metabolic therapy?
Guest: Prof. Viral Shah
Host: John Pemberton of The Glucose Never Lies
Description:
GLP-1 and GIP therapies are transforming type 2 diabetes and obesity care. But what about type 1 diabetes?
In this episode, I speak with Professor Viral Shah — a leading clinician–researcher in type 1 diabetes, automated insulin delivery, and incretin therapies. Together we explore:
- Why people with type 1 diabetes face unique metabolic challenges (peripheral insulin delivery, insulin resistance, excess glucagon).
- How GLP-1/GIP therapies may help reduce insulin needs, manage weight, smooth post-meal highs, and improve long-term outcomes.
- The latest evidence from trials in type 1 diabetes and what’s on the horizon with dual and triple agonists.
- Practical questions for people with T1D and healthcare professionals: insulin adjustment, titration, safety, and off-label prescribing.
🔗 Episode show notes & links:
https://theglucoseneverlies.com/glp1-t1d/
🌐 Key Links
The Glucose Never Lies®:
Viral Shah:
Background Reading (GNL):
Enjoy